Bio Huaxing raises ~$1.49M angel round for AI-driven gene editing

What's the deal? Bio HuaxingDealroom has a profile for this one. Try Dealroom →, a Chinese intelligent breeding services provider, has raised US$1.38M (roughly $1.49 million) in an angel round led by Xi Venture CapitalDealroom has a profile for this one. Try Dealroom →. The company builds gene-editing tools and AI algorithm models for research institutions, pharmaceutical firms, and agriculture.

What's the endgame? Bio Huaxing centres its work on omics AI models and gene editing. It aims to supply genetic big-data and biotechnology solutions across science, medicine, and farming.

The signal: The round reflects investor appetite for startups pairing AI models with gene editing — a combination increasingly seen as central to next-generation breeding and biotech.

Read more: itjuzi.com

Image credit: oakridgelabnews